PDGFB and neoplasm: Our results provide direct evidence that IDH1R132H is not only intrinsically tumor-suppressive but also resistant to functional compromise by the environmental glutamate or reducing power, which would otherwise attenuate the antagonism of IDH1R132H toward the oncogenic PDGFB when both are expressed from different transcripts.